AMEX:TMBR
Timber Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.timberpharma.comipo date
Sep 08, 2014
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus